|
| (1) Mixing test: prolongation of the aPTT in a mixture of |
| patient and normal plasma after 1-2 h incubation |
| compared to an immediate mix is typical of FVIII |
| autoantibodies. |
| (2) Clotting factor measurement: patients should have FVIII, |
| IX, X, XI, XII levels measured; an isolated low FVIII level |
| is suggestive of AHA. |
| (3) Quantification of the inhibitor titer: Bethesda assay, the test |
| should be repeated to confirm the presence of the inhibitor. |
|